newsfilter
← Latest News
Business Wire·

NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care

-- First in a suite of planned NeuroPace AI tools designed to deliver deeper data insights, support clinical outcomes and further enhance efficiency of RNS therapy -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device